Clinical Trials

Patients undergoing liver biopsy at Duke can participate in this informational database and tissue repository that will ultimately aid us in gaining a better understanding of non-alcoholic fatty liver disease (NAFLD) and other liver disease processes.

Inclusion Criteria

• Subject must be undergoing an evaluation for management of obesity, a metabolic syndrome, bariatric surgery, or NAFLD by a Duke University Health System provider.

• Subject can be male or female and must be 18 years of age or older.

• Subject's alcohol use must be consistent with NAFLD.

Exclusion Criteria

• Subjects not competent to give consent for liver biopsy

• Any standard contraindication to liver biopsy (INR >1.5, platelets <75 x103/mm3, ascites) or any technical concerns on the part of the clinician performing the biopsy that may pose unacceptable risk to the patient.

• Positive HBSAg or Positive HCV RNA

There is no compensation for participation in this study.

For more information, contact the study coordinator at 919-668-4597.